Physician profile
Heidi Cough
NPI 1477705481
$2,035.35
in general payments reported to CMS, 2019-2025
23 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $269 · 2021: $338 · 2022: $506 · 2023: $164 · 2024: $268 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $386.55 | 2019-2022 | |
| Coopersurgical, INC. | $197.62 | 2019-2023 | Summit Doppler, Mara Console |
| Pfizer INC. | $174.23 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $148.38 | 2019-2025 | |
| Hologic Sales and Service, LLC | $143.63 | 2022-2024 | Myosure Tissue Removal Device, Omni Hysteroscope, Aptima |
| Exeltis, USA INC. | $106.26 | 2019-2024 | Slynd |
| Therapeuticsmd, INC. | $102.56 | 2019-2021 | |
| Myovant Sciences INC. | $102.14 | 2021-2022 | |
| Organon LLC | $95.71 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $71.99 | 2019-2021 | |
| Aspira Women'S Health INC | $67.37 | 2022-2024 | Ova1 |
| Lupin INC. | $63.95 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $51.07 | 2024-2025 | Myfembree |
| Ethicon US, LLC | $48.05 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $46.10 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $41.75 | 2019-2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Mayne Pharma Commercial LLC | $36.57 | 2022-2025 | |
| Channel Medsystems, INC. | $34.80 | 2022-2023 | |
| Evofem Biosciences, INC. | $30.49 | 2021-2022 | |
| Meditrina | $26.81 | 2025 | |
| Biogen, INC. | $25.76 | 2024 | |
| Agile Therapeutics, INC. | $17.07 | 2021 | |
| Shield Therapeutics INC | $16.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Cough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.